Routine board appointment with no immediate trading catalyst. Monitor for any future pipeline or partnership announcements that Sandor's expertise might influence.
Price Chart
Executive Summary
AbCellera appointed Dr. Victor Sandor as an independent director on June 1, 2026. Dr. Sandor is a seasoned medical oncologist with a track record of securing drug approvals at Array BioPharma (Braftovi/Mektovi) and Incyte (Jakafi). This is a routine board appointment with no material financial impact.
Key Facts
- Dr. Victor Sandor appointed as independent director effective June 1, 2026.
- Sandor served as CMO at Array BioPharma (acquired by Pfizer) and SVP at Incyte.
- He will serve until the next annual meeting and is not on any board committees.
- Compensation follows the standard Non-Employee Director Compensation Policy.
Financial Impact
No financial figures disclosed; standard director compensation per existing policy.
Risk Factors
- No material risks identified from this filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001703057-26-000031 |
| Document: abcellera-appointsxdrxxv.htm | 0001703057-26-000031 |
| Document: 0001703057-26-000031-index-headers.html | 0001703057-26-000031 |
| Document: 0001703057-26-000031-index.html | 0001703057-26-000031 |
| Document: 0001703057-26-000031.txt | 0001703057-26-000031 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 24, 2026 5w ago | Insider Cluster | $10.61 $12.65 | ▲ +19.23% | ▲ +17.91% | $13.74 (+29.50%) |
Aug 18, 2026 6w ago | Insider Cluster | $11.12 $11.67 | ▲ +4.95% | ▲ +6.69% | $13.74 (+23.56%) |
Aug 15, 2026 6w ago | Institutional Cluster | $11.20 $11.41 | ▼ −1.88% | ▼ −3.85% | $13.74 (−22.68%) |
Aug 11, 2026 7w ago | 424B5 | $10.36 $10.46 | ▼ −1.01% | ▼ −2.91% | $13.74 (−32.69%) |
Aug 10, 2026 7w ago | 8-K | $9.34 $11.44 | ▲ +22.48% | ▲ +23.40% | $13.74 (+47.11%) |
Jul 29, 2026 9w ago | 8-K | $5.39 $12.24 | ▲ +127.09% | ▲ +122.07% | $13.74 (+154.92%) |
Jul 6, 2026 12w ago | 3 | $7.69 $5.83 | ▼ −24.19% | ▼ −25.52% | $13.74 (+78.67%) |
Jul 6, 2026 12w ago | 8-K | $7.87 $5.71 | ▼ −27.45% | ▼ −26.88% | $13.74 (+74.59%) |
Jun 5, 2026 17w ago | 8-K | $5.62 $7.87 | ▲ +40.04% | ▲ +38.17% | $13.74 (+144.48%) |
May 11, 2026 20w ago | 8-K | $4.95 $5.09 | ▲ +2.83% | ▲ +4.56% | $13.74 (+177.58%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access